Sandrine Théoleyre

Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor κB ligand (RANKL) and RANK

Sandrine Théoleyre, S. Kwan Tat, Patricia Vusio et al. · Biochemical and Biophysical Research Communications · 2006 · 92 citations

Signal Transduction, Biochemistry, Glycobiology +10

Loss of expression of TIMP3 in clear cell renal cell carcinoma

Damien Masson, Patricia Fergelot, Florence Jouan et al. · European Journal of Cancer · 2010 · 79 citations

Tumor Biology, Urology, Genitourinary Cancer +8

Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma

Sandrine Théoleyre, K Mori, Bertrand Cherrier et al. · BMC Cancer · 2005 · 72 citations · Full text

OPG/membranous–RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation

Steeve Kwan Tat, Marc Padrines, Sandrine Théoleyre et al. · Bone · 2006 · 63 citations

Proteasomal Degradation, Cell Signaling, Medicine +13

Osteoprotegerin differentially regulates protease expression in osteoclast cultures

Yohann Wittrant, Séverine Couillaud, Sandrine Théoleyre et al. · Biochemical and Biophysical Research Communications · 2002 · 60 citations

Sclerostin, Medicine, Natural Sciences +6